Research advances of corneal collagen cross-linking in the treatment of corneal diseases / 中华实验眼科杂志
Chinese Journal of Experimental Ophthalmology
; (12): 245-249, 2020.
Article
in Zh
| WPRIM
| ID: wpr-865244
Responsible library:
WPRO
ABSTRACT
Corneal collagen cross-linking (CXL) has been proved to be a very safe and effective technique to halt the progression of many cornea diseases, such as ectasia disease, infectious keratitis and ametropia.CXL techniques include conventional CXL, accelerated CXL, transepithelial CXL and photochemical CXL.CXL can prevent the progression of dilated keratopathy, postpone or avoid corneal transplant surgery, and has an auxiliary function in the treatment of bullous keratopathy, infectious keratitis except herpes virus infection, and ametropia.CXL is not effective for patients with ocular herpes virus infection and patients with thin cornea and may even worsen the development of the disease.This review summarized the advantages and disadvantages of common CXL techniques, indications, contraindications, and complications, which may help enhancing the clinical application of CXL and reducing its complications.
Full text:
1
Index:
WPRIM
Language:
Zh
Journal:
Chinese Journal of Experimental Ophthalmology
Year:
2020
Type:
Article